Atossa Therapeutics announced the appointment of Heather Rees as the company’s new CFO. Rees most recently served as Atossa’s senior VP of finance and principal accounting officer. Rees brings almost 30-years of accounting, business and financial experience to the CFO role. She has spent the last seven years of her career at Atossa having joined the company as controller in 2017.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATOS:
- Atossa announces updated protocol for trial of (Z)-Endoxifen with abemaciclib
- Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
- Atossa Therapeutics set to join Russell 3000 Index
- Atossa Set to Join Russell 3000® Index Effective June 28, 2024
- Atossa to Present at the Sidoti Small-Cap Investor Conference